MSc in Translational Health Sciences
Stuart is a tutor on the Economics and Regulation in Translational Science module.
Find out more about the MSc in Translational Health Sciences
Dr Stuart Faulkner
Programme and Operations Manager
Dr Stuart Faulkner has been a Programme and Operations Manager and Research Manager at Oxford University, since Nov 2015
Stuart currently undertakes research management roles across a variety of programmes of work within the department. Stuart also teaches on the MSc in Translational Health Sciences and co-leads a module on Economics and Regulation.
Stuart has lead a variety of work streams in large EU private-public partnerships that developed new conceptual frameworks to expedite patient access to transformative medicines (ADAPTSMART) and enhancing sustainable patient engagement across the life cycle of medicine development (PARADIGM).
Prior to this Stuart has been responsible for co-leading a variety of consultancy and policy impact projects in translating innovation in the UK as he co-lead the innovation think tank, CASMI.
Stuart’s 16-year career in science has spanned a degree in Biosciences, a PhD in neuroscience, translational models of neonatal brain injury, early phase clinical trials and developing medical devices. A four-year move to Canada saw further research into stem cell treatments for cerebral palsy, coordinating a number of large observational studies in osteoarthritis, and helping to develop new models of healthcare. Stuart has extensive experience of multi-stakeholder projects, grant applications and publications.
In his spare time Stuart is active with many sports, travelling, culture, coaching, and pursuing the love of the great outdoors.
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions.
Faulkner SD. et al, (2023), Pharmaceut Med, 1 - 10
Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines.
Faulkner SD. et al, (2021), Ther Innov Regul Sci
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action
Cavaller-Bellaubi M. et al, (2021), Therapeutic Innovation & Regulatory Science
Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study
Faulkner SD. et al, (2021), Health Expectations
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
Le Cam Y. et al, (2018), Clinical Pharmacology and Therapeutics